港股異動 | 眾安在線(6060.HK)漲4.6% 機構看高公司股價至68港元
格隆匯7月27日丨眾安在線(6060.HK)逆勢漲4.6%,現報44.25港元,最新總市值650.4億港元。國信證券指,公司於近期披露了中期業績前瞻,上半年歸母淨利潤相較於去年同期錄得不低於100%的增長。公司大健康業務路徑清晰,同時擁有互聯網健康險業務和互聯網醫院業務,可以持續探索兩者的合作模式,擁有先行先試的優勢;集團具備非常強的定向導流優勢,可以扶持其互聯網醫院迅速成長;集團基本觸達了全部的互聯網新場景,在2019年服務了4.86億用户,未來可望進一步為其互聯網醫院導流。維持對公司“買入”評級,目標價68港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.